Accelerated superfractionated radiotherapy for inflammatory breast carcinoma: Complete response predicts outcome and allows for breast conservation

International Journal of Radiation Oncology Biology Physics

Volumn 44, Issue 2, 1999, Pages 289-296

  Arthur, Douglas W ^a   Schmidt Ullrich, Rupert K ^a   Friedman, Richard B ^a   Wazer, David E ^a   Kachnic, Lisa A ^a   Amir, Cyrus ^a   Bear, Harry D ^a   Hackney, Mary Helen ^a   Smith, Thomas J ^a   Lawrence Jr , Walter ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Altered fractionation; Chemotherapy; Inflammatory breast carcinoma; Mastectomy; Radiation therapy

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; HUMAN; MASTECTOMY; MULTIMODALITY CANCER THERAPY; ORGAN PRESERVATION; PRIORITY JOURNAL; RADIATION DERMATITIS; RADIATION DOSE; RADIATION RESPONSE; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DECISION TREES; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; DOXORUBICIN; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY; METHOTREXATE; MIDDLE AGED; PROSPECTIVE STUDIES; REMISSION INDUCTION; TREATMENT FAILURE;

EID: 0032913824     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00019-X     Document Type: Article

References (36)

1. Arriagada R., Mouriesse H., Spielmann M., et al. Alternating radiotherapy and chemotherapy in non-metastatic inflammatory breast cancer. Int J Radiat Oncol Biol Phys. 19:1990;1207-1210.
2. Brun B., Otmezguine Y., Feuilhade F., et al. Treatment of inflammatory breast cancer with combination chemotherapy and mastectomy versus breast conservation. Cancer. 61:1988;1096-1103.
3. Buzdar A.U., Montague E.D., Barker J.L., et al. Management of inflammatory carcinoma of breast with combined modality approach - an update. Cancer. 47:1981;2537-2542.
4. Chu A.M., Wood W.C., Doucette J.A. Inflammatory breast carcinoma treated by radical radiotherapy. Cancer. 45:1980;2730-2737.
5. Fastenberg N.A., Buzdar A.U., Montague E.D., et al. Management of inflammatory carcinoma of the breast. Am J Clin Oncol. 8:1985;134-141.
6. Fleming R.Y., Asmar L., Buzdar A.U., et al. Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinoma. Ann Surg Oncol. 4:1997;452-461.
7. Hagelberg R.S., Jolly P.C., Anderson R.P. Role of surgery in the treatment of inflammatory breast carcinoma. Am J Surg. 148:1984;125-131.
8. Knight C.D., Martin J.K., Welch J.S., et al. Surgical considerations after chemotherapy and radiation therapy for inflammatory breast cancer. Surgery. 99:1986;385-390.
9. Kuske R.R. Diagnosis and management of inflammatory breast cancer. Semin Radiat Oncol. 4:1994;270-282.
10. Lamb C.C., Eberlein T.J., Parker L.M., et al. Results of radical radiotherapy for inflammatory breast cancer. Am J Surg. 162:1991;236-242.
11. Morris D.M. Mastectomy in the management of patients with inflammatory breast cancer. J Surg Oncol. 23:1983;255-258.
12. Perez C.A., Fields J.N., Fracasso P.M., et al. Management of locally advanced carcinoma of the breast. II. Inflammatory carcinoma. Cancer. 74:1994;466-476.
13. Pisansky T.M., Schaid D.J., Loprinzi C.L., et al. Inflammatory breast cancer: Integration of irradiation, surgery, and chemotherapy. Am J Clin Oncol. 15:1992;376-387.
14. Radie-Keane K., Wazer D.E., Schmidt-Ullrich R. Locoregional control of inflammatory carcinoma of the breast with accelerated superfractionated radiotherapy. Breast Dis. 7:1994;59-68.
15. Rouesse J., Friedman S., Sarrazin D., et al. Primary chemotherapy in the treatment of inflammatory breast carcinoma: A study of 230 cases from the Institut Gustave-Roussy. J Clin Oncol. 4:1986;1765-1771.
16. Singletary S.E., Ames F.C., Buzdar A.U. Management of inflammatory breast cancer. World J Surg. 18:1994;87-92.
17. Thomas F., Arriagada R., Spielmann M., et al. Pattern of failure in patients with inflammatory breast cancer treated by alternating radiotherapy and chemotherapy. Cancer. 76:1995;2286-2290.
18. Thoms W.W., McNeese M.D., Fletcher G.H., et al. Multimodality treatment for inflammatory breast cancer. Int J Radiat Oncol Biol Phys. 17:1989;739-745.
19. Fields J.N., Perez C.A., Kuske R.R., et al. Inflammatory carcinoma of the breast: Treatment results on 107 patients. Int J Radiat Oncol Biol Phys. 17:1989;249-255.
20. Schafer P., Alberto P., Forni M., et al. Surgery as part of a combined modality approach for inflammatory breast carcinoma. Cancer. 59:1987;1063-1067.
21. Haagenson CD. Diseases of the breast. 2nd ed. Philadelphia: WB Saunders; 1971. p. 576-584.
22. Camp E. Inflammatory carcinoma of the breast. Am J Surg. 131:1976;583-586.
23. Treves N. The inoperability of inflammatory carcinoma of the breast. Surg Gynecol Obstet. 109:1959;240-242.
24. Koh E.H., Buzdar A.U., Ames F.C., et al. Inflammatory carcinoma of the breast: Results of a combined-modality approach - M.D. Anderson Cancer Center experience. Cancer Chemother Pharmacol. 27:1990;94-100.
25. Krutchik A.N., Buzdar A.U., Blumenschein G.R., et al. Combined chemoimmunotherapy and radiation therapy of inflammatory breast carcinoma. J Surg Oncol. 11:1979;325-332.
26. Sataloff D.M., Mason B.A., Prestipino A.J., et al. Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: A determinant of outcome. J Am Coll Surg. 180:1995;297-304.
27. Maloisel F., Dufour P., Bergerat J.P., et al. Results of initial doxorubicin, 5-fluorouracil, and cyclophosphamide combination chemotherapy for inflammatory carcinoma of the breast. Cancer. 65:1990;851-855.
28. Sherry M.M., Johnson D.H., Page D.L., et al. Inflammatory carcinoma of the breast: Clinical review and summary of the Vanderbilt experience with multi-modality therapy. Am J Med. 79:1985;355-364.
29. Donegan W.L., Padrta B. Combined therapy for inflammatory breast cancer. Arch Surg. 125:1990;578-582.
30. Burton G.V., Cox E.B., Leight G.S., et al. Inflammatory breast carcinoma: Effective multimodal approach. Arch Surg. 122:1987;1329-1332.
31. Ragaz J., Jackson S.M., Ne N., et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 337:1997;956-962.
32. Overgaard M., Hanson P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med. 337:1997;949-955.
33. Fleming ID, Cooper JS, Henson DE; et al. AJCC cancer staging manual. 5th ed. Philadelphia: Lippincott-Raven; 1997. p. 171-180.
34. Fields K.K., Elfenbein G.J., Lazarus H.M., et al. Maximum tolerated doses of ifosfamide, carboplatin, and etoposide given over six days followed by autologous stem cell rescue: Toxicity profile. J Clin Oncol. 13:1995;323-332.
35. Fields K.K., Zorsky P.E., Hiemenz J.W., et al. Ifosfamide, carboplatin, and etoposide: A new regimen with a broad spectrum of activity. J Clin Oncol. 12:1994;544-552.
36. Hortobaygi G.N., Singletary S.E., McNeese M.D. Treatment of locally advanced and inflammatory breast cancer. Harris J.R., Lippman M.E., Morrow M., Hellman S. Diseases of the breast. 1996;585-599 Lippincott-Raven Publishers, Philadelphia.